What's Happening?
Researchers at the Hospital for Special Surgery (HSS) presented studies at the American Society of Regional Anesthesia and Pain Medicine meeting, focusing on the use of GLP-1 agonists in surgical patients. These medications, used for type 2 diabetes and obesity,
are increasingly prescribed for other conditions. The studies examined the impact of GLP-1s on gastric emptying and their prevalence among hip and knee arthroplasty patients. Findings showed a significant increase in GLP-1 use from 2021 to 2024, with implications for surgical safety and management.
Why It's Important?
The rising use of GLP-1 medications in diverse patient populations necessitates updated perioperative guidelines to ensure patient safety. As these drugs affect gastric emptying, they pose potential risks during surgery, such as aspiration. Understanding these risks is crucial for anesthesiologists and surgeons to adapt preoperative fasting guidelines and medication management. The studies underscore the need for evidence-based practices as GLP-1 usage expands, impacting healthcare providers and patients undergoing surgery.
What's Next?
Further research is needed to refine fasting guidelines and explore the effects of pausing GLP-1 medications before surgery. HSS plans to continue examining GLP-1 usage trends and their implications for surgical outcomes. These efforts aim to enhance patient safety and inform clinical practices, potentially leading to new guidelines for managing patients on GLP-1 medications in surgical settings.
